You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Core revenues were up 10 percent organically, while COVID-19 testing contributed $535 million to revenues in Q1 2021.
The company aims to enroll up to 2,000 people and use its Serum Epitope Repertoire Analysis technology to assess their immune responses over five years.
The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow.
The firms will use Biognosys' mass spectrometry technology to discover novel biomarkers, which they will then validate for potential clinical applications.
Ethos said Agena's MALDI-TOF-based MassArray system will allow for more rapid and lower-cost detection of SARS-Cov-2 variants than next-generation sequencing.
The company said it expects revenue growth to be approximately 57 percent year over year and non-GAAP core revenue growth to be approximately 29 percent.
A study showed that chromothripsis, a mutational process that can lead to congenital disease and cancer, can result from on-target editing with Cas9.
The researchers uncovered 25 brain proteins that appear to contribute to depression, of which 20 were not previously implicated in the condition.
Camtech will market and sell Congenica's core clinical decision support platform in Singapore, Malaysia, Japan, and South Korea.
This modular system uses a high-throughput version of the company's Applied Biosystems TaqPath COVID-19 Combo Kit, which received an EUA in March 2020.
The firm presented evidence that its DetermaIO gene expression test can help predict which bladder cancer patients are likely to respond to immune checkpoint inhibitors.
Researchers profiled interactions of the viruses with a lung-derived human cell line and effects on the transcriptome, proteome, ubiquitinome, and phosphoproteome.
HusdonAlpha Health Alliance is a nonprofit formed in 2019 to provide genomic health screening services for organizations including health systems and employers.
The company is planning to fund projects for SARS-CoV-2 testing, early disease detection, disease prognostics, and public health genomics projects.
The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector.
Last week, GenomeWeb's readers were most interested in Invitae's plan to acquire Genosity for $200 million.
The partners hope to improve variant interpretation by linking Limbus Medical's clinical decision support system with Genomenon's literature search tool.
Lucira Health's at-home molecular test received Emergency Use Authorization in November for prescription use.
DiaSorin said that the transaction is expected to be immediately accretive to its earnings per share and result in cost synergies of about $55 million within three years.
At the AACR Annual Meeting, Sharpless said NCI should focus on improving early screening, access to trials, and development of advanced drugs to realize President Biden's goal of eradicating cancer.
Sequence data on more than 800 farm or wastewater Enterobacteriaceae isolates suggested pangenome dynamics may be influenced by geography and environmental niches.
With gut microbiome data for individuals sampled four years apart, researchers saw stable and unstable gut microbial species, including those linked to host phenotypes.
News items for the week of April 5, 2021.
Researchers said that the score further may identify patients whose treatment resistance may be overcome with combination strategies targeting certain cells.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.